The global radiodermatitis treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Radiodermatitis is a medical condition (dermatitis) which is a result of radiation therapy used for the treatment of cancer. Radiodermatitis is commonly seen in approximately 95% of patients who receive radiation therapy, especially patients with breast cancer, head and neck cancer, skin cancer, lung cancer, or sarcoma. The market growth is majorly attributable to the global increase in the prevalence of cancer and thus the rising adoption of radiotherapy as a treatment option. In addition to this, the global rise in the geriatric population base further propels the growth of the global radiodermatitis market.
(Get 15% Discount on Buying this Report)
A full report of Global Radiodermatitis Treatment Market is available at: https://orionmarketreports.com/radiodermatitis-treatment-market/94098/
Some key players operating in the market include 3M Company, Smith & Nephew plc, and ConvaTec Group plc, among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in November 2021, Enveric Biosciences declared that EV102, the Company’s cannabidiol (CBD) based product in development for topical prescription treatment of radiodermatitis, has demonstrated significant and meaningful reduction in dermatitis severity, skin redness, and duration in a preclinical rodent model. EV102 was topically applied during a daily treatment regimen and resulted in a nearly 50% reduction in redness scoring severity. The significance of these preclinical findings will be evaluated in a planned human evaluation in 2022.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Product
- By Distribution Channel
- Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: 3M Co., Smith & Nephew plc, and ConvaTec Group plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Radiodermatitis Treatment Market Report by Segment
By Product
- Topical
- Dressings
- Oral
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Store
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
